2017
DOI: 10.1111/tme.12451
|View full text |Cite
|
Sign up to set email alerts
|

Prevalence of hepatitis B and human T‐lymphotropic virus infection among blood donors at a hospital in the south‐central highlands of Peru

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
1
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 4 publications
(7 reference statements)
1
1
0
Order By: Relevance
“…Similar studies from several blood banks from Medellin observed 0.06-0.176% positivity, mainly for HTLV-1 [243,244]. We also found two studies conducted on blood donors from Peru, Arequipa (0.9% HTLV-1 positive) and Abancay (3.4%, unknown subtype), and one in pregnant women from Lima (1.7% HTLV-1 positive) [253,254,256]. Concerning Chile, 0.12-0.24% HTLV positivity was described, showing higher prevalence in the central region of Valdivia than in Concepcion in the South; together with an almost 3:1 female to male ratio and a 7:1 HTLV-1 to HTLV-2 ratio [265,274].…”
Section: Htlv Prevalence and Morbidity In Latin Americasupporting
confidence: 86%
“…Similar studies from several blood banks from Medellin observed 0.06-0.176% positivity, mainly for HTLV-1 [243,244]. We also found two studies conducted on blood donors from Peru, Arequipa (0.9% HTLV-1 positive) and Abancay (3.4%, unknown subtype), and one in pregnant women from Lima (1.7% HTLV-1 positive) [253,254,256]. Concerning Chile, 0.12-0.24% HTLV positivity was described, showing higher prevalence in the central region of Valdivia than in Concepcion in the South; together with an almost 3:1 female to male ratio and a 7:1 HTLV-1 to HTLV-2 ratio [265,274].…”
Section: Htlv Prevalence and Morbidity In Latin Americasupporting
confidence: 86%
“…In Peru, HTLV-1 infections are reported in 1.2% to 3.4% of potential blood donors [10,50]. Blood products have been screened for HTLV-1 since 1997 in this country, but there is no specific program in pregnant women or neonates.…”
Section: Discussionmentioning
confidence: 99%